Divis Laboratories opened lower at ₹9,411.00, compared with its previous close of ₹9,426.00. During today's session, the stock has traded between ₹9,164.50 and ₹9,423.50, with an average traded price of ₹9,248.71. It is currently showing a downward intraday trend.
An investment of ₹10,000 made 5 years ago in Divis Laboratories is now worth
₹ 17,767.00
giving a profit of
₹ 7,767.00 (77.67%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
-141.00 (-1.50%)
Day High
₹9,423.50
Day Low
₹9,164.50
Day Open
₹9,411.00
Prev Close
₹9,426.00
Volume
4,16,650
Value Traded
₹385.35 Cr
1W Return
0.97%
1M Return
-0.40%
3M Return
35.83%
6M Return
51.80%
1Y Return
43.41%
Market Cap (₹ Cr.)
2,46,488
PE Ratio
85.10
PB Ratio
14.85
Dividend Yield
0.32%
ROE
15.32%
ROCE
18.96%
Book Value (₹)
631.38
Face Value (₹)
2.00
EPS (TTM)
33.95
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
0.97%
6 Week
-
1 Month
-0.40%
3 Month
35.83%
9 Month
43.17%
Divis Laboratories shares worth ₹23.49 crore change hands on BSE
A large-trade signal flagged approximately 24,994 shares of Divis Laboratories on BSE. Shares changed hands at ₹9400.00 per share, for a combined value of ₹23.49 crore. This is a real-time signal from trade-scanning activity, not a confirmed exchange-reported event. Official exchange disclosures on such activity are published only after market close.
13 days agoDivi's Laboratories posts 65% PAT surge in Q1FY27 on strong revenue growth
Divi's Laboratories posted a 65% YoY PAT surge to ₹902 crore in Q1FY27, with revenue rising 28% to ₹3,080 crore. The growth was supported by robust Custom Synthesis contributions and margin expansion, offsetting a forex loss of ₹7 crore compared to a gain last year.
2mo agoDivis Laboratories uploads Q1 FY27 earnings call audio for investors
Divis Laboratories Limited has made the audio recording of its Q1 FY27 earnings conference call available on its website. The call occurred on August 01, 2026, following a prior notice on July 24, 2026. The disclosure was filed with NSE and BSE under Regulation 30 of SEBI LODR, signed by Company Secretary M. Satish Choudhury.
2mo agoDivis Laboratories accepts retirement of two senior VPs
Divis Laboratories Ltd announced the retirement of Vice Presidents L. Ramesh Babu and D. Madhu Babu effective July 31, 2026. The filing, submitted under SEBI LODR Regulation 30, confirms both executives will cease to be Senior Management Personnel due to retirement, impacting procurement and projects divisions.
2mo agoDivis Laboratories fixes July 24 record date for ₹30 dividend
Divi's Laboratories Limited has fixed July 24, 2026, as the record date for a ₹30 per share dividend, subject to approval at the 36th AGM on August 10, 2026. The AGM will be held via VC/OAVM, with remote e-voting available from August 6 to August 9 for members registered as of August 3, 2026. The company has dispatched the Annual Report 2025-26 electronically and published notices in newspapers, while reminding shareholders to comply with KYC norms and tax regulations.
2mo agoDivis Laboratories reduces carbon footprint in FY 2025-26
Divis Laboratories Limited achieved a reduction of 13,500 TCO2e in GHG emissions and conserved 1,59,500 KL of water in FY 2025-26. The company validated its net-zero targets for FY 2050 with SBTi and maintained a lost time injury severity rate of 0.14.
3mo ago| Contract | Days to Expiry | LTP | Change | Change % | Volume | OI | OI Chg % |
|---|---|---|---|---|---|---|---|
| DIVISLAB OCT FUT | 15 | 9,322.00 | -115.50 | -1.22 | 3,01,900 | 42,56,200 | 0.76 |
| DIVISLAB NOV FUT | 42 | 9,361.50 | -116.00 | -1.22 | 1,25,800 | 6,17,000 | 10.12 |
| DIVISLAB DEC FUT | 78 | 9,407.50 | -108.00 | -1.14 | 13,100 | 17,000 | 65.05 |
| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹1,770.70 | +0.61% | ₹4,24,850.24 | 34.83 | +5.97% | |
| ₹4,642.90 | -0.84% | ₹1,76,600.99 | 82.55 | +31.42% | |
| ₹1,132.50 | -0.17% | ₹1,12,967.31 | 24.74 | +14.00% | |
| ₹2,059.40 | -0.47% | ₹1,11,271.90 | 102.63 | +134.89% | |
| ₹1,329.60 | +1.40% | ₹1,07,412.86 | 31.62 | -14.87% | |
| ₹1,240.00 | +0.86% | ₹1,03,500.36 | 32.26 | -1.93% | |
| ₹2,372.00 | -1.17% | ₹97,974.30 | 47.92 | -3.57% | |
| ₹1,684.60 | -1.31% | ₹96,928.16 | 26.40 | +49.04% | |
| ₹1,953.60 | +0.96% | ₹89,336.17 | 16.03 | -0.29% | |
| ₹2,265.30 | -0.78% | ₹63,932.35 | 35.82 | +16.81% | |
| ₹5,250.00 | +0.86% | ₹62,771.63 | 28.34 | -3.75% | |
| ₹351.00 | +1.34% | ₹57,202.26 | 134.86 | -0.69% |
An investment of ₹10,000 made 5 years ago in Divis Laboratories is now worth
₹ 17,767.00
giving a profit of
₹ 7,767.00 (77.67%)
Note: Past profits do not guarantee future returns.
